Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck Cancer
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
To determine the safety and tolerability of gefitinib in combination with cisplatin and
radiation (3D-CRT or IMRT) in patients with locally advanced head and neck cancer.